Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.
This article is from
The Cancer Letter
archive.
Vol. 33 No. 27 | July 13, 2007
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Clinical Trials Approved By NCI In November
December 28, 2001
TCL Archive
Doctor-Patient Interaction May Cause Racial Disparity
February 24, 2006
TCL Archive
Counseling reduces Pain, Study Shows
April 18, 1986
TCL Archive
Broder To Leave In March; Sondik To Be Acting Director
January 27, 1995
TCL Archive
Anil Potti Resigns From Duke University
November 19, 2010
TCL Archive
Single-Letter Mutation Found Responsible For Waldenstrom’s
December 30, 2011